Latest news
Can Botanix (ASX:BOT) Broaden the Cannabinoid Story? - Kalkine MediaKalkine Media · Fri, 07 Aug 2026 04:08:00 GMTBotanix Pharmaceuticals (ASX:BOT) Gains as Sofdra Commercial Rollout Remains the Key Test - KalkineKalkine · Thu, 06 Aug 2026 10:35:00 GMTBotanix (ASX:BOT): What Puts Execution In Dermatology in Focus? - Kalkine MediaKalkine Media · Thu, 06 Aug 2026 06:05:00 GMTBotanix (ASX:BOT): Can Execution In Dermatology Change the Story? - Kalkine MediaKalkine Media · Thu, 06 Aug 2026 03:09:00 GMTCan Botanix Pharmaceuticals' (ASX:BOT) Commercial Update Reshape Market Focus? - Kalkine MediaKalkine Media · Wed, 05 Aug 2026 01:55:00 GMTBotanix Pharmaceuticals (ASX:BOT): What Puts Working Capital in Focus? - Kalkine MediaKalkine Media · Tue, 04 Aug 2026 16:24:00 GMTBotanix Pharmaceuticals Cancels 3.25 Million Employee Incentive Plan Options Following Staff Departures - KalkineKalkine · Mon, 03 Aug 2026 05:18:20 GMTWhy Watch Botanix Pharmaceuticals (ASX:BOT) This August? - Kalkine MediaKalkine Media · Mon, 03 Aug 2026 03:55:00 GMT